Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Compare SP 500 and diversified funds for retirement, highlighting cost, risk, and diversification benefits to guide your decision.
25,853 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
As AI-focused crypto assets roar, Pi Network faces a defining year. This report weighs whether will network (pi) outp...
The insurance backdrop is stabilizing in mid-2026, but homeowners coverage costs stay stubbornly high. Builders and l...
A Franklin Electric insider sold 1,900 shares for about $190k, prompting questions about FELE. This guide explains in...
A veteran market strategist argues the semiconductor rally is supported by real demand and capacity constraints, not ...
Two Harbors postpones its special meeting to vote on its sale to CrossCountry Mortgage, while pushing UWM to submit a...
Investors are weighing a bold 2028 target for McDonald’s as loyalty growth and margin leverage could lift the stock, ...
A new kind of space stock is building recurring AI-powered intelligence from satellites. This article breaks down the...
As micron's earnings report almost arrives, investors weigh whether the AI memory boom can sustain MU's meteoric run....
Amazon delivered a blockbuster Q1 2026, but a record capex plan raises questions about the stock’s two-year path. Her...
Veteran investor Jeremy Grantham warns that U.S. stock valuations have grown extremely stretched, signaling a potenti...
I’ve spent week world’s top AI talks and the takeaway is sharp: talent battles and new pricing models will ripple thr...